Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Working Capital/Sales

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 1.391.101.421.241.25

What is the latest Working Capital/Sales ratio of NATCO PHARMA ?

The latest Working Capital/Sales ratio of NATCO PHARMA is 1.39 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20261.39
Mar20251.10
Mar20241.42
Mar20231.24
Mar20221.25

How is Working Capital/Sales of NATCO PHARMA Trending?

Years Working Capital/Sales % Change
Mar2026 1.39
26.36
Mar2025 1.1
-22.54
Mar2024 1.42
14.52
Mar2023 1.24
-0.80
Mar2022 1.25 -

Other Financial Ratios of NATCO PHARMA


Compare Working Capital/Sales ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,045.3 Cr 2.9% -2.7% -4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

2.9%

-2.7%

-4.9%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses